Skip to main content

James Rothman, Ph.D.

James Rothman, Ph.D.

Senior Advisor; Advisory Board Chairman

Joined Arsenal in 2010

Areas of Focus:

  • BioPharma and Life Sciences

Prior Experience:

  • Yale University School of Medicine
    Wallace Professor of Biomedical Sciences and Chair of the Department of Cell Biology
  • General Electric Healthcare
    Chief Scientist
  • Nobel Prize for Physiology or Medicine (2013)
    Recognizing his fundamental discoveries in cell biology and neuroscience
  • Stanford, Princeton, and Columbia Universities
    Professor
  • Memorial Sloan-Kettering Cancer Center
    Vice-Chairman, Sloan-Kettering Institute

Boards:

  • BioIVT
  • TractManager Holdings
  • WIRB Copernicus Group 
  • Certara (Previous)
  • Member, National Academy of Sciences (USA) and Institute of Medicine
  • Senior Advisor in Biomedical Research, General Electric
  • Genprex Advisory Board
  • Berkeley Lights
  • Pershing Square Sohn Cancer Research Alliance
  • Amersham PLC's Scientific Advisory Board (Previous)
  • Johnson & Johnson Scientific Advisory Board (Previous)
  • ARIAD Pharmaceuticals Co-Founder (Previous)
  • Merck Scientific Advisory Board (Previous)
  • Consultant to top management at GlaxoSmithKline, Eli Lilly, and Genentech (Previous)

Education:

  • Ph.D. in Biological Chemistry
    Harvard
  • B.A. in Physics
    Yale College